Mechanism(s) of bioreductive activation: The example of diaziquinone (AZQ)
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 6 (4) , 405-445
- https://doi.org/10.1016/0891-5849(89)90087-7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nucleiBiochemistry, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activityArchives of Biochemistry and Biophysics, 1983
- Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductaseBiochemical Pharmacology, 1982
- The effect of superoxide generation on the ability of mitochondria to take up and retain Ca2+FEBS Letters, 1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Potential bioreductive alkylating agents. 1. Benzoquinone derivativesJournal of Medicinal Chemistry, 1972
- Generation of free radicals from phenazine methosulfate, streptonigrin, and riboflavin in bacterial suspensions.Proceedings of the National Academy of Sciences, 1965